Hello and Welcome to Patientsville.com, Your Source for all TAKEPRON information. We are dedicated to provide You with TAKEPRON safety information. Learn about TAKEPRON serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
TAKEPRON Safety Reports
Total TAKEPRON reports: 9.TAKEPRON FDA safety alerts: No.
Reported hospitalizations: 5.
Take TAKEPRON Side Effects Survey or Share Your TAKEPRON Story. Read More Here.
Physician from JAPAN reported TAKEPRON problem on Sept 12, 2006. Male patient, 70 years of age, was diagnosed with reflux oesophagitis and was treated with TAKEPRON. After drug was administered, patient experienced the following problems/side effects: oculomucocutaneous syndrome. TAKEPRON dosage: unknown. During the same period patient was treated with LASIX, LOXONIN. Patient was hospitalized. Patient recovered.
TAKEPRON problem was reported by a Consumer or non-health professional from JAPAN on Jan 23, 2007. Male patient, 75 years of age, was diagnosed with gastric ulcer haemorrhage and was treated with TAKEPRON. After drug was administered, patient experienced the following problems/side effects: haematemesis, pyrexia, renal failure acute, shock. TAKEPRON dosage: 30 MG PER ORAL. During the same period patient was treated with OMEPRAZOLE, SIGMART, PREDNISOLONE, HALCION, MUCOSTA. Patient recovered.
Consumer or non-health professional from JAPAN reported TAKEPRON problem on Mar 09, 2007. Female patient, 68 years of age, was diagnosed with reflux oesophagitis and was treated with TAKEPRON. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, myalgia. TAKEPRON dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with NEUROTROPIN. Patient was hospitalized. Patient recovered.
TAKEPRON problem was reported by a Consumer or non-health professional from JAPAN on July 10, 2006. Female patient, 60 years of age, was diagnosed with gastric ulcer and was treated with TAKEPRON. After drug was administered, patient experienced the following problems/side effects: abdominal distension, blood pressure increased, dyspnoea, face oedema, oedema peripheral, pruritus, rash, renal failure acute. TAKEPRON dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with MUCOSTA. Patient recovered.
Consumer or non-health professional from JAPAN reported TAKEPRON problem on May 31, 2006. Female patient was treated with TAKEPRON. After drug was administered, patient experienced the following problems/side effects: autoimmune disorder, encephalopathy. TAKEPRON dosage: unknown. Patient was hospitalized. Patient recovered.
TAKEPRON problem was reported by a Health Professional from JAPAN on July 31, 2006. Female patient, 51 years of age, was treated with TAKEPRON. After drug was administered, patient experienced the following problems/side effects: cataract, erythema multiforme, oesophageal ulcer, stevens-johnson syndrome. TAKEPRON dosage: unknown. Patient recovered.
Consumer or non-health professional from JAPAN reported TAKEPRON problem on Sept 06, 2006. Male patient, 70 years of age, was diagnosed with reflux oesophagitis and was treated with TAKEPRON. After drug was administered, patient experienced the following problems/side effects: oculomucocutaneous syndrome. TAKEPRON dosage: 30 MG (30 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with LOXONIN. Patient was hospitalized. Patient recovered.
TAKEPRON problem was reported by a Consumer or non-health professional from JAPAN on Oct 31, 2006. Male patient, 78 years of age, was diagnosed with gastrointestinal haemorrhage and was treated with TAKEPRON. After drug was administered, patient experienced the following problems/side effects: condition aggravated, diabetic nephropathy, disease progression, renal impairment. TAKEPRON dosage: 15 MG PER ORAL. During the same period patient was treated with FERROMIA, AMINOFLUID, LACTEC. Patient recovered.
Consumer or non-health professional from JAPAN reported TAKEPRON problem on July 23, 2007. Male patient, 56 years of age, was diagnosed with gastric ulcer and was treated with TAKEPRON. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, oedema peripheral. TAKEPRON dosage: 15 MG (15 MG, 1 IN 1 D); PER ORAL. During the same period patient was treated with LANSAP. Patient was hospitalized. Patient recovered.